Lv1
44 积分 2025-01-25 加入
CXCR2-engineered biomimetic prodrug nanoplatform restores STING signaling and enhances anti-glioma immunity
11天前
已完结
DDI–CYP: Metabolism ensemble models for drug-drug interaction predictions
1个月前
已完结
Insights into CYP450 polymorphisms and their impact on drug metabolism in Alzheimer’s disease therapy
2个月前
已完结
Development and validation of a quick and sensitive UPLC-MS/MS method for measuring ensartinib in HLMs: investigation of structural alerts associated with metabolic lability and in silico toxicity
3个月前
已完结
LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib
3个月前
已完结
Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes
3个月前
已完结
Drug-induced enzyme activity inhibition and CYP3A4 genetic polymorphism significantly shape the metabolic characteristics of furmonertinib
6个月前
已完结
Befotertinib: First Approval
6个月前
已完结
Validation of population pharmacokinetic models: a comparison of internal and external validation approaches for hydrochlorothiazide
6个月前
已完结
THE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGS
7个月前
已完结